Mismatch repair cancer syndrome: genes and variants
Explore variant evidence for Mismatch repair cancer syndrome across 4 analyzed proteins (MLH1, PMS2, MSH6, MSH2). Linked ClinVar records include 7 pathogenic or likely pathogenic variants, 105 variants of uncertain significance and 74 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Mismatch repair cancer syndrome
MLH1: DNA mismatch repair protein Mlh1
The protein partners with PMS2 to form MutL alpha, a core complex in post-replicative DNA mismatch repair. By helping correct copying errors in DNA, MLH1 protects genome stability, and inherited MLH1 variants are a major cause of Lynch syndrome.
4 ClinVar pathogenic / likely pathogenic and 35 uncertain variants in MLH1 have source records linked to Mismatch repair cancer syndrome. Association strength is not clinical gene validity.
PMS2: Mismatch repair endonuclease PMS2
Together with MLH1, it provides endonuclease activity needed to complete DNA mismatch repair after replication errors are recognized. Germline loss-of-function variants cause Lynch syndrome, while biallelic variants cause constitutional mismatch-repair deficiency.
1 ClinVar pathogenic / likely pathogenic and 90 uncertain variants in PMS2 have source records linked to Mismatch repair cancer syndrome. Association strength is not clinical gene validity.
MSH6: DNA mismatch repair protein Msh6
Together with MSH2, it recognizes single-base mismatches and small insertion-deletion loops during DNA replication and initiates mismatch repair. Germline loss-of-function variants cause Lynch syndrome, while biallelic variants can cause constitutional mismatch-repair deficiency.
1 ClinVar pathogenic / likely pathogenic and 33 uncertain variants in MSH6 have source records linked to Mismatch repair cancer syndrome. Association strength is not clinical gene validity.
MSH2: DNA mismatch repair protein Msh2
The protein forms mismatch-recognition complexes with MSH6 or MSH3 that detect base mismatches and insertion-deletion loops in DNA. This first step of mismatch repair helps preserve genome integrity, and inherited MSH2 variants are associated with Lynch syndrome.
1 ClinVar pathogenic / likely pathogenic and 21 uncertain variants in MSH2 have source records linked to Mismatch repair cancer syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Mismatch repair cancer syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MLH1 Y343D | 343 | Pathogenic / likely pathogenic (★★) | |
| MLH1 S556N | 556 | Interaction with EXO1 | Pathogenic / likely pathogenic (★★) |
| MLH1 Y684D | 684 | Pathogenic / likely pathogenic (★★) | |
| MSH2 G426R | 426 | Pathogenic / likely pathogenic (★★) | |
| MSH6 A1230P | 1230 | Pathogenic / likely pathogenic (★★) | |
| PMS2 I668V | 668 | Pathogenic / likely pathogenic (★★) | |
| MLH1 A111S | 111 | Pathogenic / likely pathogenic (★) |
Same protein, different disease
- Lynch syndrome also has ClinVar records linked to MLH1 variants; they fall mostly in different places as the Mismatch repair cancer syndrome variants (120 pathogenic / likely pathogenic).
- Lynch syndrome also has ClinVar records linked to PMS2 variants; they fall mostly in different places as the Mismatch repair cancer syndrome variants (19 pathogenic / likely pathogenic).
- Lynch syndrome also has ClinVar records linked to MSH2 variants; they fall mostly in different places as the Mismatch repair cancer syndrome variants (26 pathogenic / likely pathogenic).
- Lynch syndrome also has ClinVar records linked to MSH6 variants; they fall mostly in different places as the Mismatch repair cancer syndrome variants (23 pathogenic / likely pathogenic).
Diseases related to Mismatch repair cancer syndrome
- Lynch syndrome, also linked to MLH1, MSH2, MSH6 and PMS2
- Colon carcinoma, also linked to MLH1, MSH2, MSH6 and PMS2
- Breast and/or ovarian cancer, also linked to MLH1, MSH2, MSH6 and PMS2
- Endometrial carcinoma, also linked to MLH1, MSH2, MSH6 and PMS2
- Ovarian cancer, also linked to MLH1, MSH2 and MSH6
- Hereditary breast ovarian cancer syndrome, also linked to MLH1, MSH2 and PMS2
- Colorectal cancer, also linked to MLH1, MSH2 and MSH6
- Gastric cancer, also linked to MLH1, MSH6 and PMS2
- Muir-Torré syndrome, also linked to MLH1 and MSH2
- Lynch-like syndrome, also linked to MLH1 and MSH6
- Hereditary breast cancer, also linked to MLH1
Frequently asked questions
Which genes have records linked to Mismatch repair cancer syndrome?
This view contains 4 analyzed proteins: MLH1, PMS2, MSH6, MSH2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 7 pathogenic or likely pathogenic variants, 105 variants of uncertain significance and 74 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 202 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center